United Therapeutics | UTHR - Ebitda


United Therapeutics reported $334.2M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD -9.78M 19.98M Jun/2026
Baxter International USD 474M 165M Jun/2026
Bayer EUR 1.62B 529M Sep/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 450.8M 198.9M Jun/2026
BioMarin Pharmaceutical USD 54.32M 167.99M Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Halozyme Therapeutics USD 336.16M 7.34M Sep/2026
Insmed USD -80.97M 93.7M Sep/2026
Ionis Pharmaceuticals USD -95.22M 9.99M Sep/2026
J&J USD 8.99B 721M Jun/2026
Lexicon Pharmaceuticals USD -12.04M 15.95M Sep/2025
Moderna USD -687M 571M Jun/2026
Omeros USD -47.96M 7.39M Sep/2023
Pfizer USD 6.36B 350M Sep/2026
PTC Therapeutics USD 161.9M 99.92M Jun/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Sarepta Therapeutics USD -3.14M 33.31M Sep/2026
Teva Pharmaceutical Industries USD 1.5B 1.02B Sep/2026
United Therapeutics USD 334.2M 20.8M Sep/2026
Vertex Pharmaceuticals USD 888.6M 436.6M Sep/2026